Increased risk of coeliac disease in patients with congenital hypothyroidism

Stefano Stagi1, Cristina Manoni, Cecilia Cecchi

  • 1Department of Paediatrics, University of Florence, Anna Meyer Children's Hospital, Italy. stefano.stagi@yahoo.it

Insights

Children with congenital hypothyroidism (CH) show a higher prevalence of coeliac disease (CD). Further research is needed to understand the link between CH and CD.

Area of Science:

  • Pediatric Endocrinology
  • Gastroenterology
  • Autoimmunology

Background:

  • Congenital hypothyroidism (CH) is a condition where infants are born with an underactive thyroid gland.
  • Coeliac disease (CD) is an autoimmune disorder triggered by gluten consumption.
  • The co-occurrence of CH and CD has been reported infrequently.

Purpose of the Study:

  • To investigate the prevalence of coeliac disease (CD) in children diagnosed with permanent congenital hypothyroidism (CH).
  • To assess the familial occurrence of autoimmune diseases in children with CH compared to controls.

Main Methods:

  • Studied 79 children with permanent CH (age 3.1-12.1 years) and 182 age/sex-matched controls.
  • Collected family history of autoimmune diseases and evaluated serum for CD antibodies (IgA, antigliadin, anti-endomysium, anti-transglutaminase).
  • Confirmed CD diagnosis via jejunal biopsy in antibody-positive subjects.

Main Results:

  • A significantly higher prevalence of autoimmune diseases in the families of CH patients (22% vs. 7.9%, p < 0.001).
  • 6 CH patients (7.6%) tested positive for CD antibodies, compared to 1% in controls (p < 0.005).
  • Histological confirmation of CD in 5 out of 6 antibody-positive CH patients (6.3% overall prevalence).

Conclusions:

  • Children with permanent CH exhibit a higher prevalence of coeliac disease.
  • Routine monitoring for CD is recommended in pediatric patients with CH.
  • Further studies are required to elucidate the underlying mechanisms connecting CH and CD.
Abstract

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...